In a setback to Sun Pharma-Ranbaxy merger process, Andhra Pradesh High Court has issued orders to Bombay Stock Exchange and National Stock Exchange to maintain interim status quo on the......
Sun Pharma on Wednesday denied insider trading charges against Silverstreet Developers LLP -- its wholly owned arm -- in the $4 billion acquisition deal of Ranbaxy Laboratories. Silverstreet......